Decision

Bristol-Myers Squibb Canada Co. v. Apotex Inc., 2019 FC 1379 (Apixaban*)

Justice Zinn - 2019-11-01

Read full decision. Automatically generated summary:

This is a motion brought by the Defendant seeking leave to serve and file a reply report of Dr. Alan Parr [the Reply Report]. The Reply Report addresses the report served and filed by the Plaintiffs’ expert, Professor Martyn C. Davies, in response to the initial expert report of Dr. Parr.

Decision relates to:

  • T-351-18 - BRISTOL-MYERS SQUIBB CANADA CO. et al v. APOTEX INC.

 

Canadian Intellectual Property